{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:31:20Z","timestamp":1791354680130,"version":"4.3.1"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation"],"published-print":{"date-parts":[[2003,9,9]]},"abstract":"<jats:p>\n            <jats:bold>\n              <jats:italic>Background\u2014<\/jats:italic>\n            <\/jats:bold>\n            We recently reported that arterial superoxide (O\n            <jats:sub>2<\/jats:sub>\n            <jats:sup>\u2212<\/jats:sup>\n            ) is augmented by increased endothelin-1 (ET-1) in deoxycorticosterone acetate (DOCA)-salt hypertension, a model of low renin hypertension. Tetrahydrobiopterin (BH\n            <jats:sub>4<\/jats:sub>\n            ), a potent reducing molecule with antioxidant properties and an essential cofactor for endothelial nitric oxide synthase, protects against O\n            <jats:sub>2<\/jats:sub>\n            <jats:sup>\u2212<\/jats:sup>\n            \u2013induced vascular dysfunction. However, the interaction between O\n            <jats:sub>2<\/jats:sub>\n            <jats:sup>\u2212<\/jats:sup>\n            and BH\n            <jats:sub>4<\/jats:sub>\n            on endothelial function and the underlying mechanisms are unknown.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Methods and Results\u2014<\/jats:italic>\n            <\/jats:bold>\n            The present study tested the hypothesis that BH\n            <jats:sub>4<\/jats:sub>\n            deficiency due to ET-1\u2013induced O\n            <jats:sub>2<\/jats:sub>\n            <jats:sup>\u2212<\/jats:sup>\n            leads to impaired endothelium-dependent relaxation and that gene transfer of human guanosine 5\u2032-triphosphate (GTP) cyclohydrolase I (GTPCH I), the first and rate-limiting enzyme for BH\n            <jats:sub>4<\/jats:sub>\n            biosynthesis, reverses such deficiency and endothelial dysfunction in carotid arteries of DOCA-salt rats. There were significantly increased arterial O\n            <jats:sub>2<\/jats:sub>\n            <jats:sup>\u2212<\/jats:sup>\n            levels and decreased GTPCH I activity and BH\n            <jats:sub>4<\/jats:sub>\n            levels in DOCA-salt compared with sham rats. Treatment of arteries of DOCA-salt rats with the selective ET\n            <jats:sub>A<\/jats:sub>\n            receptor antagonist ABT-627, NADPH oxidase inhibitor apocynin, or superoxide dismutase (SOD) mimetic tempol abolished O\n            <jats:sub>2<\/jats:sub>\n            <jats:sup>\u2212<\/jats:sup>\n            and restored BH\n            <jats:sub>4<\/jats:sub>\n            levels. Basal arterial NO release and endothelium-dependent relaxations were impaired in DOCA-salt rats, conditions that were improved by apocynin or tempol treatment. Gene transfer of GTPCH I restored arterial GTPCH I activity and BH\n            <jats:sub>4<\/jats:sub>\n            levels, resulting in reduced O\n            <jats:sub>2<\/jats:sub>\n            <jats:sup>\u2212<\/jats:sup>\n            and improved endothelium-dependent relaxation and basal NO release in DOCA-salt rats.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Conclusions\u2014<\/jats:italic>\n            <\/jats:bold>\n            These results indicate that a BH\n            <jats:sub>4<\/jats:sub>\n            deficiency resulting from ET-1\u2013induced O\n            <jats:sub>2<\/jats:sub>\n            <jats:sup>\u2212<\/jats:sup>\n            via an ET\n            <jats:sub>A<\/jats:sub>\n            \/NADPH oxidase pathway leads to endothelial dysfunction, and gene transfer of GTPCH I reverses the BH\n            <jats:sub>4<\/jats:sub>\n            deficiency and endothelial dysfunction by reducing O\n            <jats:sub>2<\/jats:sub>\n            <jats:sup>\u2212<\/jats:sup>\n            in low renin mineralocorticoid hypertension.\n          <\/jats:p>","DOI":"10.1161\/01.cir.0000089082.40285.c3","type":"journal-article","created":{"date-parts":[[2003,8,19]],"date-time":"2003-08-19T00:46:34Z","timestamp":1061253994000},"page":"1238-1245","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":116,"title":["Gene Transfer of Human Guanosine 5\u2032-Triphosphate Cyclohydrolase I Restores Vascular Tetrahydrobiopterin Level and Endothelial Function in Low Renin Hypertension"],"prefix":"10.1161","volume":"108","author":[{"given":"Jie-Sheng","family":"Zheng","sequence":"first","affiliation":[{"name":"From the Department of Pharmacology and Toxicology and the Neuroscience Program, Michigan State University, East Lansing, Mich (J.-S.Z., X.-Q.Y., K.J.L., G.D.F., A.F.C.); Department of Neurosurgery, the First Affiliate Hospital, College of Medicine, Zhejiang University, Hangzhou, P.R. China (J.-S.Z.); Altana Pharma AG, Konstanz, Germany (C.H.); Department of Psychiatry and Behavioral Neurosciences, Wayne State University, Detroit, Mich (G.K.); and GenVec, Inc, Gaithersburg, Md (I.K.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Qun","family":"Yang","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology and Toxicology and the Neuroscience Program, Michigan State University, East Lansing, Mich (J.-S.Z., X.-Q.Y., K.J.L., G.D.F., A.F.C.); Department of Neurosurgery, the First Affiliate Hospital, College of Medicine, Zhejiang University, Hangzhou, P.R. China (J.-S.Z.); Altana Pharma AG, Konstanz, Germany (C.H.); Department of Psychiatry and Behavioral Neurosciences, Wayne State University, Detroit, Mich (G.K.); and GenVec, Inc, Gaithersburg, Md (I.K.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith J.","family":"Lookingland","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology and Toxicology and the Neuroscience Program, Michigan State University, East Lansing, Mich (J.-S.Z., X.-Q.Y., K.J.L., G.D.F., A.F.C.); Department of Neurosurgery, the First Affiliate Hospital, College of Medicine, Zhejiang University, Hangzhou, P.R. China (J.-S.Z.); Altana Pharma AG, Konstanz, Germany (C.H.); Department of Psychiatry and Behavioral Neurosciences, Wayne State University, Detroit, Mich (G.K.); and GenVec, Inc, Gaithersburg, Md (I.K.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory D.","family":"Fink","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology and Toxicology and the Neuroscience Program, Michigan State University, East Lansing, Mich (J.-S.Z., X.-Q.Y., K.J.L., G.D.F., A.F.C.); Department of Neurosurgery, the First Affiliate Hospital, College of Medicine, Zhejiang University, Hangzhou, P.R. China (J.-S.Z.); Altana Pharma AG, Konstanz, Germany (C.H.); Department of Psychiatry and Behavioral Neurosciences, Wayne State University, Detroit, Mich (G.K.); and GenVec, Inc, Gaithersburg, Md (I.K.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Hesslinger","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology and Toxicology and the Neuroscience Program, Michigan State University, East Lansing, Mich (J.-S.Z., X.-Q.Y., K.J.L., G.D.F., A.F.C.); Department of Neurosurgery, the First Affiliate Hospital, College of Medicine, Zhejiang University, Hangzhou, P.R. China (J.-S.Z.); Altana Pharma AG, Konstanz, Germany (C.H.); Department of Psychiatry and Behavioral Neurosciences, Wayne State University, Detroit, Mich (G.K.); and GenVec, Inc, Gaithersburg, Md (I.K.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Kapatos","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology and Toxicology and the Neuroscience Program, Michigan State University, East Lansing, Mich (J.-S.Z., X.-Q.Y., K.J.L., G.D.F., A.F.C.); Department of Neurosurgery, the First Affiliate Hospital, College of Medicine, Zhejiang University, Hangzhou, P.R. China (J.-S.Z.); Altana Pharma AG, Konstanz, Germany (C.H.); Department of Psychiatry and Behavioral Neurosciences, Wayne State University, Detroit, Mich (G.K.); and GenVec, Inc, Gaithersburg, Md (I.K.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imre","family":"Kovesdi","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology and Toxicology and the Neuroscience Program, Michigan State University, East Lansing, Mich (J.-S.Z., X.-Q.Y., K.J.L., G.D.F., A.F.C.); Department of Neurosurgery, the First Affiliate Hospital, College of Medicine, Zhejiang University, Hangzhou, P.R. China (J.-S.Z.); Altana Pharma AG, Konstanz, Germany (C.H.); Department of Psychiatry and Behavioral Neurosciences, Wayne State University, Detroit, Mich (G.K.); and GenVec, Inc, Gaithersburg, Md (I.K.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex F.","family":"Chen","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology and Toxicology and the Neuroscience Program, Michigan State University, East Lansing, Mich (J.-S.Z., X.-Q.Y., K.J.L., G.D.F., A.F.C.); Department of Neurosurgery, the First Affiliate Hospital, College of Medicine, Zhejiang University, Hangzhou, P.R. China (J.-S.Z.); Altana Pharma AG, Konstanz, Germany (C.H.); Department of Psychiatry and Behavioral Neurosciences, Wayne State University, Detroit, Mich (G.K.); and GenVec, Inc, Gaithersburg, Md (I.K.)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_1_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.91.1.248"},{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.2001.281.3.H981"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.91.1.139"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(99)00134-0"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200314172"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.38.5.1044"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.87.7.566"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj3490353"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.103.9.1282"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.101.14.1722"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200104000-00011"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.38.5.1107"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/atvb.22.2.249"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000051459.74466.46"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000047875.43777.79"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.8.6_pt_2.ii61"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.27.6.1245"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.80.3.327"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2001.00583.x"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.23.12568"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0169-328X(96)00073-3"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2002.01074.x"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.79.2.336"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.0000049166.33035.62"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(02)00460-1"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020905"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(01)02074-X"},{"key":"e_1_3_3_28_2","first-page":"447","volume":"117","year":"1997","journal-title":"J Hum Hypertens"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.103.2.263"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/heart.87.3.264"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-200002000-00001"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.atv.0000038144.37823.bf"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.86.2.e36"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/atvb.21.4.496"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj3470001"}],"container-title":["Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.CIR.0000089082.40285.C3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T18:27:28Z","timestamp":1715020048000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.CIR.0000089082.40285.C3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9,9]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2003,9,9]]}},"alternative-id":["10.1161\/01.CIR.0000089082.40285.C3"],"URL":"https:\/\/doi.org\/10.1161\/01.cir.0000089082.40285.c3","relation":{},"ISSN":["0009-7322","1524-4539"],"issn-type":[{"value":"0009-7322","type":"print"},{"value":"1524-4539","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,9,9]]},"assertion":[{"value":"2003-08-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}